Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Campbell D. Joyner"'
Autor:
William E. Boden, David P. Faxon, Christopher B. Granger, Valentin, Campbell D. Joyner, Shamir R. Mehta, Current Oasis trial investigators, Jean-François Tanguay, Rafael Diaz, Matthias Bossard, A Budaj, Peggy Gao, Adnan Kastrati, Salim Yusuf, Phillippe Gabriel Steg, G. Di Pasquale
Publikováno v:
European Heart Journal. 40
Background Approximately 10% of patients presenting with myocardial infarction (MI) do not have obstructive coronary artery disease (MINOCA). The role of antiplatelet therapy and outcomes in this group remain unclear. We assessed prognosis and the ef
Autor:
Campbell D. Joyner, Susan Chrolavicius, Andrzej Budaj, Rizwan Afzal, Kari Niemelä, Denis Xavier, Vicent Valentin, Peggy Gao, Matti Niemelä, Petr Widimsky, Sanjit S. Jolly, John A. Cairns, Salim Yusuf, Alvaro Avezum, Philippe Gabriel Steg, Basil S. Lewis, Shamir R. Mehta, Sunil V. Rao
Publikováno v:
The Lancet. 377:1409-1420
Summary Background Small trials have suggested that radial access for percutaneous coronary intervention (PCI) reduces vascular complications and bleeding compared with femoral access. We aimed to assess whether radial access was superior to femoral
Autor:
Campbell D. Joyner, Husam Abdel-Qadir, Mark B. N. Hansen, Ching Lau, Ilan Lashevsky, Eugene Crystal
Publikováno v:
Canadian Journal of Cardiology. 26:475-480
Cardiac resynchronization therapy (CRT) can be a valuable treatment for heart failure. However, there are high nonresponse rates using current CRT inclusion criteria.To assess the value of three-dimensional echocardiography (3DE) in predicting respon
Autor:
Shamir R, Mehta, Jean-Pierre, Bassand, Susan, Chrolavicius, Rafael, Diaz, John W, Eikelboom, Keith A A, Fox, Christopher B, Granger, Sanjit, Jolly, Campbell D, Joyner, Hans-Jurgen, Rupprecht, Petr, Widimsky, Rizwan, Afzal, Janice, Pogue, W C L, Wu
Publikováno v:
New England Journal of Medicine. 363:930-942
A b s t r ac t Background Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidencebased guidelines for dosing have not been established for eit
Autor:
F.R.C.P.C. Davinder S. Jassal M.D., F.R.C.P.C. Kwan L. Chan M.D., F.R.C.P.C. Kapil M. Bhagirath M.D., F.R.C.P.C. A. Shekhar Pandey M.D., F.R.C.P.C. Jean G. Dumesnil M.D., F.R.C.P.C. John Jue M.D., F.R.C.P.C. Koon K. Teo M.D., F.R.C.P.C. Randall A. Sochowski M.D., F.R.C.P.C. Campbell D. Joyner M.D., F.R.C.P.C. Peter J. Giannoccaro M.D., F.R.C.P.C. James W. Tam M.D.
Publikováno v:
Echocardiography. 27:174-179
Background: Bicuspid aortic valve (BAV) is the leading cause of aortic stenosis in patients younger than the age of 50. A classification scheme of BAVs is based upon leaflet orientation: Type I (fusion of right and left coronary cusps) and Type II (f
Autor:
Rizwan Afzal, Campbell D. Joyner, Salim Yusuf, Andrzej Budaj, John W. Eikelboom, Susan Chrolavicius, Christopher B. Granger, Shamir R. Mehta, Keith A.A. Fox, Ron J.G. Peters, Lars Wallentin, Jean-Pierre Bassand
Publikováno v:
European heart journal, 30(6), 655-661. Oxford University Press
Budaj, A, Eikelboom, J W, Mehta, S R, Afzal, R, Chrolavicius, S, Bassand, J-P, Fox, K A A, Wallentin, L, Peters, R J G, Granger, C B, Joyner, C D, Yusuf, S, OASIS 5 Investigators & Husted, S 2009, ' Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes ', European Heart Journal, vol. 30, no. 6, pp. 655-61 . https://doi.org/10.1093/eurheartj/ehn358
Budaj, A, Eikelboom, J W, Mehta, S R, Afzal, R, Chrolavicius, S, Bassand, J-P, Fox, K A A, Wallentin, L, Peters, R J G, Granger, C B, Joyner, C D, Yusuf, S, OASIS 5 Investigators & Husted, S 2009, ' Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes ', European Heart Journal, vol. 30, no. 6, pp. 655-61 . https://doi.org/10.1093/eurheartj/ehn358
Udgivelsesdato: 2009-Mar AIMS: Bleeding in patients with coronary artery disease has been linked with adverse outcomes. We examined the incidence and outcomes after bleeding in 20 078 patients with acute coronary syndromes (ACS) enrolled in the OASIS
Autor:
Susan Chrolavicius, Campbell D. Joyner, Salim Yusuf, Shamir R. Mehta, Andrzej Budaj, Keith A.A. Fox, Jean Pierre Bassand, Christopher B. Granger, Rizwan Afzal, Maria Grazia Franzosi, Marcus Flather, Ron J.G. Peters
Publikováno v:
American heart journal, 157(3), 502-508. Mosby Inc.
Background The OASIS-5 (Organization to Assess Strategies in Ischemic Syndromes-5) trial demonstrated that fondaparinux was noninferior to enoxaparin while reducing the risk of bleeding by 50%. The objectives of our study were to assess the effects o
Autor:
A. Shekhar Pandey, Peter J. Giannoccaro, Jean G. Dumesnil, Kwan L. Chan, Campbell D. Joyner, John Jue, Isabelle Gaboury, Randall A. Sochowski, Kapil M Bhagirath, Davinder S. Jassal, James W. Tam, Koon K. Teo
Publikováno v:
European Heart Journal. 29:1542-1547
Aims Mitral annular calcification (MAC) is characterized by calcium and lipid deposition in the annular fibrosa of the mitral valve. Although individuals with MAC are at increased risk of cardiovascular events, little is known about the significance
Autor:
Mehta, Christopher B. Granger, Janice Pogue, Campbell D. Joyner, Salim Yusuf, Jean Pierre Bassand, Susan Chrolavicius, Lars Wallentin, Rizwan Afzal, A Budaj, Ron J.G. Peters, Keith A.A. Fox
Publikováno v:
JAMA, 295(13), 1519-1530. American Medical Association
Context Despite many therapeutic advances, mortality in patients with acute ST-segment elevation myocardial infarction (STEMI) remains high. The role of additional antithrombotic agents is unclear, especially among patients not receiving reperfusion